Belviq: the New FDA Approved Obesity-Fighting Drug

Jan.14 (Bloomberg) –- Arena Pharmaceuticals President & CEO Jack Lief and Eisai President & CEO Lonnel Coats discuss the new obesity-fighting drug, Belviq, how it works and the potential side effects with Mark Crumpton on Bloomberg Television's "Taking Stock." (Source: Bloomberg)

Oil Down for 3rd Week, OPEC Meets in Kuwait
46:50 - Oil headed for a third weekly drop this month, weighed down by record U.S. crude supplies while investors await a meeting between OPEC and its allies that may signal whether output curbs will be extended. Bloomberg's Yousef Gamal El-Din reports on "Bloomberg Markets." (Source: Bloomberg)
  • Merck KgaA, Pfizer Cancer Drug to Cost $13,000 a Month
  • Aviva's Diebel Sees No Macro Impact From Healthcare Bill
  • Italy Junior Minister Sees Brexit as EU Opportunity